N. Karalı

发表

Synthesis and anticonvulsant activity of some new thiosemicarbazone and 4-thiazolidone derivatives bearing an isatin moiety.

N. Karalı, A. Gürsoy, 1994, Farmaco.

Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.

C. Supuran, N. Karalı, Özlen Güzel-Akdemir, 2015, Organic & biomolecular chemistry.

2-(5-Fluoro-1-methyl-2-oxoindolin-3-ylidene)-N-[4-(methylsulfanyl)phenyl]hydrazine-1-carbothioamide

N. Karalı, M. Akkurt, Z. Atioğlu, 2017 .

Exploiting Pretrained Biochemical Language Models for Targeted Drug Design

K. Ulgen, K. Ülgen, Elif Ozkirimli, 2022, Bioinformatics.

Synthesis and Pharmacology of New Dithiocarbamic Acid Esters Derived from Phenothiazine and Diphenylamine

N. Karalı, A. Gürsoy, O. Özdemir, 1999, Archiv der Pharmazie.

Antioxidant and cytotoxic properties of novel spirocyclic benzothiazolines

N. Karalı, Gökçe Cihan-Üstündağ, G. Çapan, 2017 .

Isatin analogs as novel inhibitors of Candida spp. β-carbonic anhydrase enzymes.

C. Supuran, N. Karalı, Özlen Güzel-Akdemir, 2016, Bioorganic & medicinal chemistry.

Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida β-carbonic anhydrase enzyme

C. Supuran, A. Angeli, N. Karalı, 2019, Journal of enzyme inhibition and medicinal chemistry.

Anti-proliferative effects of indomethacin, acemetacin and their tromethamine salts in HCT116 human colon cancer cells

N. Karalı, M. Muftuoglu, B. Somuncu, 2021, İstanbul Journal of Pharmacy.

Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.

N. Karalı, N. Ozsoy, S. Ozbey, 2010, European journal of medicinal chemistry.

Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinones.

N. Karalı, A. Gürsoy, 2003, European journal of medicinal chemistry.

Synthesis and antitubercular activity of 4-(3-coumarinyl)-3-cyclohexyl-4-thiazolin-2-one benzylidenehydrazones.

N. Karalı, A. Gürsoy, A. Kocabalkanli, 2002, Farmaco.

Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives

C. Pannecouque, J. Neyts, E. Clercq, 2005 .

Synthesis and anticonvulsant activity of new acylthiosemicarbazides and thiazolidones.

N. Karalı, A. Gürsoy, 1995, Farmaco.

Synthesis, Characterization and Primary Antituberculosis Activity Evaluation of 4-(3-Coumarinyl)-3-benzyl-4-thiazolin-2-one Benzylidenehydrazones

N. Karalı, A. Gürsoy, 2003 .

New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors

C. Supuran, N. Karalı, A. Akdemir, 2022, Archiv der Pharmazie.

Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives.

A. Dimoglo, V. Kovalishyn, N. Shvets, 2007, Bioorganic & medicinal chemistry.

New spiroindolinones bearing 5-chlorobenzothiazole moiety

N. Karalı, A. Can, Görkem Ermut, 2014, Journal of enzyme inhibition and medicinal chemistry.

5-Chlorobenzothiazole-2-spiro-3′-indolin-2′-one

N. Karalı, O. Büyükgüngör, M. Akkurt, 2010, Acta crystallographica. Section E, Structure reports online.

Synthesis and antifungal activity of new carbamodithioic acid esters derived from 3-acetylcoumarin

N. Karalı, A. Gürsoy, N. Cesur, 1996 .

Synthesis and Primary Cytotoxicity Evaluation of New 5‐Bromo‐3‐substituted‐hydrazono‐1H‐2‐indolinones

N. Karalı, A. Gürsoy, N. Terzioğlu, 2002, Archiv der Pharmazie.

New cyclohexylidenehydrazide and 4-aza-1-thiaspiro [4.5]decan-3-one derivatives of 3-phenyl-4 (3H)-quinazolinones

N. Karalı, A. Gürsoy, M. Kiraz, 1998 .

Synthesis and primary cytotoxicity evaluation of new 5-nitroindole-2,3-dione derivatives.

N. Karalı, 2002, European journal of medicinal chemistry.

Three novel compounds of 5-trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone: Synthesis, crystal structures and molecular interactions

N. Karalı, F. B. Kaynak, S. Özbey, 2013 .

Synthesis and chemotherapeutic activities of 5-chloro-1H-indole-2,3-dione 3-thiosemicarbazones

N. Karalı, İ. Çetin, M. Topcul, 2013 .

Molecular and crystal structure of 1-methyl 5-trifluoromethoxy-1H-indole-2,3-dione 3-[4-(4-methoxyphenyl)thiosemicarbazone]

N. Karalı, M. Akkurt, Z. Atioğlu, 2021, İstanbul Journal of Pharmacy.

Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones.

N. Karalı, Zekiye Şeyma Sevinçli, G. N. Duran, 2020, Bioorganic chemistry.

Some 3-hydrazono-2-indolinones and N-Mannich bases as potential anticonvulsants.

Ş. Demirayak, N. Karalı, A. Gürsoy, 1996, Farmaco.

Synthesis and Preliminary CNS Depressant Activity Evaluation of New 3‐[(3‐Substituted‐5‐methyl‐4‐thiazolidinon‐2‐ylidene)hydrazono]‐1H‐2‐indolinones and 3‐[(2‐Thioxo‐3‐substituted‐4,5‐imidazolidine‐dion‐1‐yl)imino] ‐ 1H‐2‐indolinones

N. Karalı, A. Gürsoy, S. Oezkirimli, 1998, Archiv der Pharmazie.

Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.

N. Karalı, A. Salman, O. Güzel, 2008, Bioorganic & medicinal chemistry.

Interpreting Chemical Words of a Data-driven Segmentation Method as Protein Family Pharmacophores and Functional Groups

K. Ulgen, Elif Ozkirimli, Arzucan Ozgur, 2022, 2210.14642.

Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.

C. Supuran, A. Angeli, N. Karalı, 2017, Bioorganic & medicinal chemistry.

Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors.

N. Karalı, Çağla Begüm Apaydın, Nurten Özsoy, 2022, Future medicinal chemistry.

Antiviral activity and molecular modeling studies on 1H-indole-2,3-diones carrying a naphthalene moiety

N. Karalı, Gökçe Cihan-Üstündağ, Füsun Göktaş, 2023, Journal of Molecular Structure.

Synthesis of 4-(3-coumarinyl)-3-benzyl-4-thiazolin-2-one 4-methylbenzylidenehydrazone and determination of the isomeric structure by X-ray analysis

N. Karalı, A. Gürsoy, S. Özbey, 2003 .

4-(3-Coumarinyl)-4-thiazolin-2-one Benzylidene-hydrazones with Antituberculosis Activity

N. Karalı, A. Gürsoy, 2000, Arzneimittelforschung.

Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides.

N. Karalı, Çağla Begüm Apaydın, Kübra Demir-Yazıcı, 2021, Future medicinal chemistry.

New Cyclohexylidenehydrazide and 4‐Aza‐1‐thiaspiro[4.5]decan‐3‐one Derivatives of 3‐Phenyl‐4(3H)‐quinazolinones.

N. Karalı, E. Ilhan, M. Kiraz, 1998 .

(2Z)-2-(5-Fluoro-1-methyl-2-oxoindolin-3-ylidene)N-(3-fluorophenyl)hydrazine-1-carbothioamide

N. Karalı, M. Akkurt, Z. Atioğlu, 2017 .

Selective Cytotoxic Effects of 5-Trifluoromethoxy-1H-indole-2,3-dione 3-Thiosemicarbazone Derivatives on Lymphoid-originated Cells.

K. Akgün-Dar, N. Karalı, Z. Karakaş, 2021, Anti-Cancer Agents in Medicinal Chemistry.

Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives

N. Karalı, İ. Çetin, M. Topcul, 2019, Istanbul Journal of Pharmacy.

COVID-19 Tedavisinde Antisitokin Hedefli Yakla ş ı mlar Anti-cytokine Targeted Approaches in COVID-19 Treatment

N. Karalı, Bilimleri Enstitüsü, Bilimleri Dergisi, 2021 .

Synthesis, Characterization and Preliminary Anticonvulsant Evaluation of New Indoline-2,3-dione Derivatives.

N. Karalı, N. Ergenç, G. Çapan, 1998 .

5‐Fluoro/(trifluoromethoxy)‐2‐indolinone derivatives with anti‐interleukin‐1 activity

B. Erman, N. Lack, N. Karalı, 2023, Archiv der Pharmazie.

Exploring Data-Driven Chemical SMILES Tokenization Approaches to Identify Key Protein-Ligand Binding Moieties.

K. Ulgen, Elif Ozkirimli, N. Karalı, 2022, Molecular informatics.

Simultaneous determination of medazepam and hyoscine butylbromide in tablets by second-derivative ultraviolet spectrometry

N. Karalı, A. Gürsoy, S. Özkırımlı, 1998 .